調査レポートカテゴリー： visiongain, 世界, 医療/バイオ

Pharmaceutical Anti-Counterfeiting Technologies Market Forecast 2016-2026

医薬品偽造防止技術の世界市場予測2016-2026

◆タイトル：Pharmaceutical Anti-Counterfeiting Technologies Market Forecast 2016-2026
◆商品コード：VGAIN60629
◆調査・発行会社：visiongain
◆発行日：2016年4月
◆ページ数：226
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Sigle UserGBP3,499 ⇒換算￥489,860見積依頼/購入/質問フォーム
Departmental/Five UserGBP3,899 ⇒換算￥545,860見積依頼/購入/質問フォーム
Site LicenseGBP4,999 ⇒換算￥699,860見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM（デジタル著作権管理）付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

 【レポートの概要】

当調査レポートでは、医薬品偽造防止技術の世界市場について調査・分析し、以下の構成でお届けいたします。
1. レポート概要

2. 医薬品偽造の概要

3. 医薬品偽造防止技術の世界市場 2016-2026

4. 医薬品バーコード市場 2016-2026

5. 医薬品RFID2次市場 2016-2026

6. 医薬品タガント2次市場 2016-2026

7. 医薬品ホログラム/OVD市場 2016-2026

8. その他の医薬品偽造防止技術市場: 売上予測 2016-2026

9. 医薬品偽造防止技術の国別市場 2016-2026

10. 医薬品偽造防止市場のパイプライン

11. 医薬品偽造防止市場における主要企業

12. 医薬品偽造防止技術市場の定性分析 2016-2026

13. 調査インタビュー

14. 結論

Our new study reveals trends, R&D progress, and predicted revenues
Our new report discusses issues and events affecting the pharmaceutical anti-counterfeiting technologies market. You will find discussions, including qualitative analyses:
• Increasing demand for pharmaceutical anti-counterfeiting technologies due to increasing cases of counterfeit drugs
• Government requirements on serialisation in key national markets
• Protection of brand name and revenues
• Cost of implementing anti-counterfeiting technologies
• Dilution impact on supply chains
• Online market for pharmaceutical drugs

You will see discussions of technological, commercial, political and economic matters, with emphasis on the competitive landscape and business outlooks.

Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. There you find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT and STEP Analysis), company profiles and commercial developments.

Read the full transcripts of two exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales, including:
• Dr Fred Jordan, CEO of AlpVision, a world’s leader in digital invisible technologies for product authentication and counterfeit protection.
• Dr Jamie Barras, technical manager of CONPHIRMER, a collaborative EU project aimed at developing a radiofrequency-spectroscopic sensor for identifying counterfeit medicines within packaging.

Discover How to Stay Ahead
Forecasts from 2016-2026 and other analyses reveal the commercial prospects
This study investigates commercial trends and revenues of the pharmaceutical anti-counterfeiting market from 2016 to 2026, as well as historical data. In particular it discusses sales potentials of the main submarkets of pharmaceutical anti-counterfeiting technology: barcodes, RFID, holograms/OVD and taggants. In addition, it includes qualitative analysis of anti-counterfeiting technology in the pipeline. This analysis also examines strengths and weaknesses of the pharmaceutical anti-counterfeiting market as well as the opportunities and threats it will face. It provides a discussion of the prominent companies with products already available or in the pipeline, who are vying for position in that industry. Furthermore, the study examines 8 leading national markets for pharmaceutical anti-counterfeiting, with analyses and revenue forecasts presented.

Discover sales predictions for the world market and submarkets
Predictions of leading products’ sales – what’s possible for those pharma anti-counterfeiting market
Along with revenue prediction for the overall world market, you see forecasts to 2026 for these five submarkets:
• Barcodes
• RFID
• Holograms/OVD
• Taggants
• Other anti-counterfeiting technologies
Over the course of the forecast period, traditional barcode technology and new radio-frequency identification (RFID) technology will compete for market share.

With our investigation you gain business research and analysis with submarkets sales predictions and discussions. You find analysis of competition, as well as commercial drivers and restraints affecting each submarket. See what’s likely to achieve the most success.

You gain competitive advantages by understanding the dynamics, opportunities and challenges facing the pharmaceutical anti-counterfeiting technologies market. As well as finding technologies that will likely to achieve the most success.

What are the prospects in the leading regions and countries?
In our study you will find individual revenue forecasts to 2026 for the leading regional and national markets:
• US
• Japan
• EU5
• China
• India
• Brazil
• Russia
• Mexico
• Rest of the World

The US and the EU dominated shares of the market in 2015. However, the emerging markets will increase their market shares throughout the forecast period as the demand for such technologies will be greatest in areas where illegal counterfeiting is greatest.

Leading companies and the potential for market growth
Research and development – assess innovation, trends and possibilities
Overall world revenue for pharmaceutical anti-counterfeiting technologies will reach $3.4bn in 2015, our work forecasts. We predict strong revenue growth from 2016 to 2026. Rising consumption of counterfeit drugs, government regulatory mandates and FDA initiatives, technological advancements and the rapid growth of the RFID submarket will drive sales to 2026.
Our work shows you which companies hold the greatest potential. See profiles of 15 leading companies, including these:
• 3M
• Alien Technology
• AlpVision
• Angstrom Technologies
• Authentix
• Avery Dennison
• Colorcon
• Covectra
• Everest Holovisions
• InkSure Technologies
• Intermec
• Multi Packaging Solutions
• ThermoFisher Scientific
• TruTag Technologies
• UPM Raflatac
• Zebra Technologies

A company profile gives you the following information:
• Discussion of a company’s activities and outlook
• Recent financial results
• Profiles of key anti-counterfeiting technologies
• Assessment of recent developments – mergers and acquisitions (M&A), new products, and collaborations, including alliances, partnerships and joint ventures

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

How the pharma anti-counterfeiting market report helps you
This report features news, insights, the latest developments and an in depth survey of the pharmaceutical anti-counterfeiting technology market with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors. You cannot afford to be without this latest report from visiongain.

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Our 226 page report provides 50 tables and 66 figures covering 4 different submarkets. 8 national markets are covered in addition to 15 leading companies. Discover the most lucrative areas in the industry and the future market prospects. You will see financial results, interviews, trends, opportunities, and revenue predictions. Development of new and existing technologies in unison with an increasing occurrence of illegal counterfeit activity will increase worldwide sales of such products from 2016 to 2026, our study shows.

Benefit your work now through our updated study, gaining original industry and market analysis:
• Revenue to 2026 for the global pharmaceutical anti-counterfeiting technology market – discover the sales potential of that industry
• Revenues to 2026 for the leading submarkets of anti-counterfeiting technology – find sales predictions, seeing how they can compete and succeed
• Forecasts to 2026 for 8 national markets in the Americas, Europe and Asia – discover the best countries and regions for commercial expansion
• Activities of established, rising and emerging companies – hear about firms’ products, capabilities, advances and outlooks, also with industry opinions
• Discussions of R&D – investigate progress in that industry, finding technological and commercial outlooks and opportunities
• Analysis of what stimulates and restrains the pharmaceutical anti-counterfeiting technology market – assess challenges and strengths for technology, their developers, producers and sellers, helping you compete and stay ahead.

【レポートの目次】

1. Report Overview
1.1 Overview of the Pharmaceutical Anti-Counterfeiting Market
1.2 Why You Should Read this Report
1.3 How this Study Delivers
1.4 Main Questions Answered by this Report
1.5 Who is this Investigation For?
1.6 Method of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Associated visiongain Reports
1.9 About visiongain

2. Introduction to Pharmaceutical Counterfeiting
2.1 Drug Counterfeiting: A Thorn in the Side of the Pharma Industry in Recent Years
2.1.1 Regional Differences Hindering Information Exchange
2.1.2 The Incidence of Counterfeited Pharmaceuticals is Increasing
2.1.3 Asia and Europe are Counterfeiting Hotspots in 2014
2.2 What are the Most Commonly Counterfeited Drugs?
2.3 Types of Counterfeit Drugs
2.3.1 Substandard Pharmaceutical Products as Counterfeits
2.3.2 Global Outsourcing of Active Pharmaceutical Ingredients (APIs)
2.4 Why are Drugs Counterfeited?
2.5 Methods of Producing Pharmaceutical Counterfeits
2.5.1 Moving Counterfeits into the Pharmaceutical Supply Chain
2.5.2 Corruption Within the Pharmaceutical Distribution System
2.6 The Role of the Internet in Pharmaceutical Counterfeiting
2.6.1 Online Pharmacies: A Cheap Distribution System for Pharma Counterfeits
2.6.2 Legal Online Pharmacies: A Convenient and quick Way of Dispensing Medication
2.6.3 Verifying the Authenticity of Online Pharmacies
2.7 The Global Costs of Pharmaceutical Counterfeiting
2.7.1 The Impact of Pharmaceutical Counterfeiting on Consumers
2.7.2 The Impact of Counterfeiting on Healthcare Providers
2.7.3 The Impact of Counterfeiting on Pharma Manufacturers
2.7.4 The Impact of Pharmaceutical Counterfeiting on Governments
2.7.5 The Impact of Counterfeiting on the Global Pharmaceutical Industry
2.8 Operation Pangea: Europol’s Fight Against Online Counterfeiting
2.8.1 Legislative Deficiencies Aiding Counterfeiting Operations
2.9 Factors Driving Pharmaceutical Counterfeiting
2.9.1 An Erratic Supply or Shortage of drugs Promotes Counterfeiting
2.9.2 Price Differentials and High Price Medicines Drive People to Cheaper Counterfeit Alternatives
2.9.3 Drug Misuse Creates a Market for Counterfeiting
2.9.4 Trade Through Free-Trade Zones/Free Ports is an Important Route for Counterfeiters
2.9.5 The Trade of Pharmaceuticals Through Several Intermediaries Helps Hide Counterfeit Drugs
2.9.6 Counterfeiters Target Developed Markets
2.9.7 Parallel Trade – A Counterfeiting Route in Europe
2.10 Leading Anti-Counterfeiting Technologies and Applications
2.10.1 Passive Anti-Counterfeiting Technologies
2.10.2 Active Anti-Counterfeiting Technologies
2.10.3 Mass Encoding Techniques

3. The Global Market for Pharmaceutical Anti-Counterfeiting Technologies, 2016-2026
3.1 World Pharmaceutical Anti-counterfeiting Technologies Market in 2014 and 2015
3.1.1 Breakdown of the World Pharmaceutical Anti-Counterfeiting Market by Technology in 2015
3.2 World Pharmaceutical Anti-Counterfeiting Technologies Market: Sales Forecast 2016-2026
3.2.1 World Pharmaceutical Anti-Counterfeiting Technologies Market: Sales Forecast, 2014-2020
3.2.2 World Pharmaceutical Anti-counterfeiting Technologies Market: Sales Forecast, 2020-2026
3.3 RFID Leads the World Pharmaceutical Anti-Counterfeiting Technologies Market
3.4 How Will Market Shares Change to 2026?
3.5 Drivers and Restraints for the Pharmaceutical Anti-Counterfeiting Technologies Market, 2016-2026

4. The Pharmaceutical Barcodes Market, 2016-2026
4.1 Barcodes as Anti-counterfeiting Technology
4.2 Pharmaceutical Barcodes Submarket in 2014 and 2015
4.3 Pharmaceutical Barcodes Market: Sales Forecast 2016-2026
4.4 Pharmaceutical Barcodes Market: Drivers and Restraints, 2016-2026

5. The Pharmaceutical RFID Submarket 2016-2026
5.1 RFID as Anti-counterfeiting Technology
5.2 Pharmaceutical RFID Market in 2014 and 2015
5.3 Pharmaceutical RFID Market: Sales Forecast 2016-2026
5.4 Pharmaceutical RFID Submarket: Drivers and Restraints 2016-2026
5.4.1 Drivers of the of the Pharmaceutical RFID Submarket
5.4.2 Restraints of the Pharmaceutical RFID Submarket

6. Pharmaceutical Taggants Submarket 2016-2026
6.1 Taggants as Anti-counterfeiting Technology
6.2 Pharmaceutical Taggants Submarket in 2014 and 2015
6.3 Pharmaceutical Taggants Market: Sales Forecast 2016-2026
6.4 Pharmaceutical Taggants Market: Drivers and Restraints 2016-2026

7. Pharmaceutical Holograms/OVD Market 2016-2026
7.1 Holograms as Anti-Counterfeiting Technology
7.2 Pharmaceutical Holograms/OVD Market in 2014 and 2015
7.3 Pharmaceutical Holograms/OVD Market: Sales Forecast 2016-2026
7.4 Pharmaceutical Holograms/OVD Market: Drivers and Restraints 2016-2026

8. Other Pharmaceutical Anti-Counterfeiting Technologies Market: Sales Forecast 2016-2026

9. National Markets for Pharmaceutical Anti-Counterfeiting Technology, 2016-2026
9.1 Geographical Breakdown of the World Pharmaceutical Anti-Counterfeiting Market in 2014-2015
9.2 World Pharmaceutical Anti-Counterfeiting Technologies Market: National Markets Forecast 2016-2026
9.3 How Will National Market Shares Change by 2026?
9.4 The US Pharmaceutical Anti-Counterfeiting Market
9.4.1 The US Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.4.2 Trends and Developments in the US Pharmaceutical Anti-Counterfeiting Market
9.5 The EU5 Pharmaceutical Anti-Counterfeiting Technologies Market
9.5.1 The EU5 Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.5.2 EU5 Enforcement of Drug Serialisation in 2016
9.6 The Japanese Pharmaceutical Anti-Counterfeiting Market
9.6.1 The Japanese Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.6.2 The Uptake of Anti-Counterfeit Technology in Japan
9.7 The Chinese Pharmaceutical Anti-Counterfeiting Market
9.7.1 The Chinese Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.7.2 Chinese Pharmaceutical Anti-Counterfeiting Measures from Past to Present
9.8 The Indian Pharmaceutical Anti-Counterfeiting Market
9.8.1 The Indian Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.8.2 India’s Award Winning DAVA Project will Restore
9.9 The Brazilian Pharmaceutical Anti-Counterfeiting Market
9.9.1 The Brazilian Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.9.2 Brazilian Anti-Counterfeiting Measures from Past to Present
9.10 The Russian Pharmaceutical Anti-Counterfeiting Market
9.10.1 The Russian Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.10.2 Russia’s New Anti-Counterfeiting Programme Due Q1 2017
9.11 The Mexican Pharmaceutical Anti-Counterfeiting Market
9.11.1 The Mexican Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.11.2 Mexico Signs the Anti-Counterfeiting Trade Agreement

10. Pipeline for the Pharmaceutical Anti-Counterfeiting Market
10.1 Breathable Holograms at the University of Michigan
10.2 3D Ingestible Barcodes
10.3 3D Barcodes
10.4 Nanoparticle Ink
10.5 Chipped Pharmaceuticals In Vivo
10.6 Stable Isotope Excipients for Drug Identification
10.7 Agamatrix Diagnostic Strip

11. Leading Companies in the Pharmaceutical Anti-Counterfeit Market
11.1 Leading Pharmaceutical Anti-Counterfeiting Technology Manufacturers by Segment in 2016
11.2 3M Overview
11.2.1 3M Financial Figures
11.3 Alien Technologies Overview
11.3.1 Recent Developments at Alien Technologies
11.4 AlpVision Overview
11.4.1 AlpVision Products
11.4.2 Recent developments at AlpVision
11.5 Angstrom Technologies Overview
11.6 Authentix Overview
11.6.1 Product-Specific Track-and-Trace Solutions
11.6.2 Packaging Solutions
11.7 Avery Dennison Overview
11.7.1 Avery Dennison Financial Figures
11.8 Colorcon Overview
11.8.1 Colorcon’s Taggants: On-Dose ID
11.8.2 Recent Developments for Colorcon
11.9 Covectra Overview
11.9.1 Recent Developments at Covectra
11.10 Everest Holovisions Overview
11.11 Honeywell Acquires Intermec
11.11.1 Honeywell Financial Figures
11.12 Multi Packaging Solutions Overview
11.12.1 MPS Recent Developments
11.13 ThermoFisher Scientific Overview
11.13.1 ThermoFisher Scientific Financial Figures
11.13.2 Recent Developments at ThermoFisher Scientific
11.14 TruTag Technologies Overview
11.14.1 Recent Developments at TruTag Technologies
11.15 UPM Raflatac Overview
11.15.1 UPM Raflatac Recent Developments
11.16 Zebra Technologies Overview
11.16.1 Zebra Technologies Financial Figures
11.16.2 Zebra Technologies Recent Developments

12. Qualitative Analysis of the Pharmaceutical Anti-Counterfeiting Technologies Market, 2016-2026
12.1 SWOT Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market, 2016-2026
12.2 Strengths of the Anti-Counterfeiting Technology Market
12.2.1 Growing Interest from Pharmaceutical Companies in Tackling Counterfeiting
12.2.2 Organisations Promoting Awareness and Implementation of Anti-Counterfeiting Solutions
12.2.3 Track-and-Trace Solutions Boosting Supply Chain Efficiency
12.2.4 New Technologies Providing More Comprehensive Anti-Counterfeiting Protection
12.2.5 Litigation Proceedings over Counterfeit Products Affecting Profitability
12.3 Weaknesses
12.3.1 Lack of Standardisation Across the Industry Will Impede Technology Adoption
12.3.2 Insufficient Quantitative Measurement of the Effectiveness of Anti-Counterfeiting Technologies
12.3.3 Technology Reliability and the Ease of Integration into Manufacturing Processes
12.3.4 Lack of Cooperation Between Governmental Organisations Aids Drug Counterfeiters
12.4 Opportunities
12.4.1 Constantly Evolving Technologies Allows for Product Innovation
12.4.2 Anti-Counterfeiting Technologies for the Prevention of Online Fraud
12.5 Threats
12.5.1 High Volume of Counterfeiting Activities Could Devalue Anti-Counterfeiting Solutions
12.5.2 Developing Countries Lack Infrastructure to effectively Deal with Counterfeiting
12.5.3 Rate of Innovation May be Outpaced by Counterfeiters
12.6 STEP Analysis of the World Pharmaceutical Anti-Counterfeiting Technologies Market, 2016-2026
12.7 Social Factors Affecting the Pharmaceutical Anti-Counterfeiting Market
12.7.1 Weak Enforcement of Legislation
12.7.2 Corruption is a Hindrance to Eradicating Pharmaceutical Counterfeiting
12.7.3 Changing Public Perception and Consumer Education
12.7.4 Concerns Over Privacy
12.8 Technological Factors
12.8.1 Smartphone Read and Verify: A Customer Empowerment Tool
12.8.2 US FDA Counterfeit Detection Device
12.8.3 UV and IR Inks Being Used Covertly for Increased Security
12.8.4 Potential Replacements for Barcodes
12.8.5 SigNature DNA
12.9 Economic Factors
12.9.1 Implementation Costs of Anti-Counterfeiting Technologies
12.9.2 Anti-Counterfeiting Technologies Require R&D Investment
12.10 Political Factors
12.10.1 Who: The IMPACT Programme
12.10.2 Interpol Operations
12.10.3 Anti-Counterfeiting Trade Agreement (ACTA)
12.10.4 The Fagan Case: Effects of Litigation on Players in the Drug Supply Chain
12.10.5 Legislations for Supply Chain Security
12.10.6 E-pedigree: Catalyst for Product Serialisation
12.10.7 UK MHRA: Falsified Medical Products Strategy
12.10.8 EU’s Falsified Medicines Directive

13. Research Interview
13.1 Interview with Dr Fred Jordan, CEO of AlpVision
13.1.1 On AlpVision and its Products
13.1.2 On the Problem of Counterfeiting Now and in the Future
13.2 Interview with Dr Jamie Barras, Technical Manager for CONPHIRMER
13.2.1 On the CONPHIRMER Consortium
13.2.2 On the Problem of Counterfeiting Now and in the Future

14. Conclusions
14.1 Pharmaceutical Anti-Counterfeiting Technologies: A Growing Market
14.2 Leading Pharmaceutical Anti-Counterfeiting Technologies Submarkets in 2015-2026
14.3 Leading National Markets in 2015
14.4 The Future of the Pharmaceutical Anti-Counterfeiting Technologies
14.4.1 Government Mandates Will Fuel Growth in the Market
14.4.2 The US Will Continue to Dominate the Market
14.4.3 New Directives Will Ensure track-and-Trace Market Leadership
14.4.4 European Preference for Mandated 2D Barcode Technology
14.4.5 Enhances Regulation of Online Pharmacies Necessary for Anti-Counterfeiting Technologies to be Effective
14.4.6 Market Expansion Will be Dependent on the Development of Industry-wide Standards
14.4.7 What Will Succeed in the Pharmaceutical Anti-Counterfeiting Technologies Market?

Table 1.1 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2026
Table 2.1 Global Reported Incidents of Drug Counterfeiting, 2009-2014
Table 2.2 Global Reported Incidents of Drug Counterfeiting by Region & Regional Percentage (%), 2014
Table 2.3 Classification of Counterfeit Pharmaceutical Products
Table 2.4 Characteristics of an Ideal Anti-counterfeiting Technology
Table 2.5 Advantages and Disadvantages of Overt and Covert Technologies
Table 2.6 Types of Anti-counterfeiting Technologies Used in the Pharmaceutical Industry by Category
Table 3.1 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2014 and 2015
Table 3.2 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2026
Table 3.3 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: CAGR (%) by Technology in 2014-2020, 2020-2026 and 2014-2026
Table 3.4 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Market Shares (%) by Technology, 2015, 2020 and 2026
Table 4.1 Comparison of 2D Barcode and RFID Technology
Table 4.2 Barcodes Submarket Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2026
Table 5.1 RFID Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2026
Table 6.1 Taggants Submarket Forecast: Revenues ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
Table 7.1 Holograms/OVD Submarket Forecast: Revenues ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
Table 8.1 Others Submarket Forecast: Revenues ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
Table 9.1 World Pharmaceutical Anti-Counterfeiting Technologies Market: Revenues ($m) by Region, 2014 and 2015
Table 9.2 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%) by Region, 2016-2026
Table 9.3 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Market Shares (%) by Region, 2015, 2020 and 2026
Table 9.4 US Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 9.5 EU5 Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 9.6 Japanese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 9.7 Chinese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 9.8 Indian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 9.9 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 9.10 Russian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 9.11 Mexican Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 11.1 Leading RFID Technology Manufacturers, 2016
Table 11.2 Leading Holographic Labelling Technology Manufacturers, 2016
Table 11.3 Leading Taggants Technology Manufacturers, 2016
Table 11.4 Other Leading Anti-counterfeiting Technology Manufacturers, 2016
Table 11.5 3M: Revenue ($m) and Revenue Shares (%) by Business Segment, 2015
Table 11.6 3M Historical Sales: Revenue ($m), AGR (%), 2010-2015
Table 11.7 Alien Technologies: Portfolio of RFID Readers, 2016
Table 11.8 Alien Technologies: Portfolio of RFID Inlays and Their Relative Performances in Pharma Applications, 2016
Table 11.9 AlpVision: Portfolio of Pharmaceutical Anti-counterfeiting Solutions, 2016
Table 11.10 Angstrom Technologies: Portfolio of Anti-Counterfeiting Solutions, 2016
Table 11.11 Avery Dennison: Portfolio of RFID Inlays for Use in Pharmaceuticals, 2016
Table 11.12 Avery Dennison: Revenue ($m) and Revenue Shares (%) by Business Segment, 2015
Table 11.13 Avery Dennison Historical Sales: Revenue ($m), AGR (%), 2010-2015
Table 11.14 Everest Holovision: Portfolio of Pharma Products and Applications, 2016
Table 11.15 Honeywell’s Intermec: Portfolio of Products and Descriptions, 2016
Table 11.16 Honeywell Historical Sales: Revenue ($m), AGR (%), 2010-2015
Table 11.17 ThermoFisher Scientific Historical Sales: Revenue ($m), AGR (%), 2010-2015
Table 11.18 UPM Raflatac: Portfolio of Product Groups and Descriptions, 2016
Table 11.19 Zebra Technologies Historical Sales: Revenue ($m), AGR (%), 2010-2014
Table 12.1 SWOT Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market, 2016-2026
Table 12.2 Selected Instances of Counterfeiting Activities, 2011-2016
Table 12.3 STEP Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market, 2016-2026

Figure 1.1 World Anti-counterfeiting Market Segmentation by Technology Overview
Figure 2.1 Global Reported Incidents of Drug Counterfeiting, 2009-2014
Figure 2.2 Global Reported Incidents of Drug Counterfeiting by Region, 2014
Figure 2.3 Global Reported Incidents of Drug Counterfeiting by Regional Percentage (%), 2014
Figure 2.4 Most Common Types of Drugs Counterfeited in Developed and Emerging Countries, 2016
Figure 2.5 Flow Chart of the Route Taken by Counterfeit Pharma Products Entering the Legal Supply Chain
Figure 2.6 Basic Components of a RFID System: Antenna, Transceiver and Transponder
Figure 3.1 World Pharmaceutical Anti-Counterfeiting Technologies Market: Revenues ($m) by Technology, 2014
Figure 3.2 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2015
Figure 3.3 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 3.4 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 3.5 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2016-2026
Figure 3.6 World Pharmaceutical Anti-counterfeiting Market Forecast: CAGR (%) by Technology in 2014-2020 and 2020-2026
Figure 3.7 World Pharmaceutical Anti-counterfeiting Market Forecast: CAGR (%) by Technology in 2014-2026
Figure 3.8 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Technology, 2015
Figure 3.9 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Technology, 2020
Figure 3.10 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Technology, 2026
Figure 3.11 World Pharmaceutical Anti-counterfeiting Technologies Market: Drivers and Restraints, 2016-2026
Figure 4.1 Barcodes Market Forecast: Revenues ($m), 2016-2026
Figure 4.2 Barcodes Market Forecast: AGR (%), 2016-2026
Figure 4.3 Barcodes Market Forecast: Drivers and Restraints, 2016-2026
Figure 5.1 RFID Market Forecast: Revenues ($m), 2014-2026
Figure 5.2 RFID Market Forecast: AGR (%), 2016-2026
Figure 5.3 RFID Market Forecast: Drivers and Restraints, 2016-2026
Figure 6.1 Taggants Submarket Forecast: Revenues ($m), 2016-2026
Figure 6.2 Taggants Submarket Forecast: AGR (%), 2016-2026
Figure 6.3 Taggants Submarket Forecast: Drivers and Restraints, 2016-2026
Figure 7.1 Holograms/OVD Submarket Forecast: Revenue ($m), 2016-2026
Figure 7.2 Holograms/OVD Submarket Forecast: AGR (%), 2016-2026
Figure 7.3 Holograms/OVD Market Forecast: Drivers and Restraints, 2016-2026
Figure 8.1 Others Submarket Forecast: Revenue ($m), 2016-2026
Figure 8.2 Others Submarket Forecast: AGR ($m), 2016-2026
Figure 9.1 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2014
Figure 9.2 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2015
Figure 9.3 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2016-2026
Figure 9.4 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2015
Figure 9.5 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2020
Figure 9.6 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2026
Figure 9.7 US Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), 2016-2026
Figure 9.8 US Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 9.9 EU5 Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 9.10 EU5 Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 9.11 Japanese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 9.12 Japanese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 9.13 Chinese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 9.14 Chinese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 9.15 Indian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 9.16 Indian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 9.17 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 9.18 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 9.19 Russian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 9.20 Russian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 9.21 Mexican Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 9.22 Mexican Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 11.1 3M: Revenue Shares (%) by Business Segment, 2015
Figure 11.2 3M Historical Sales: Revenue ($m), 2010-2015
Figure 11.3 Authentix’s Global Monitoring Service: A Three Step Programme
Figure 11.4 Avery Dennison: Revenue Shares (%) by Business Segment, 2015
Figure 11.5 Avery Dennison Historical Sales: Revenue ($m), 2010-2015
Figure 11.6 Honeywell Historical Sales: Revenue ($m), 2010-2015
Figure 11.7 ThermoFisher Scientific Historical Sales: Revenue ($m), 2010-2015
Figure 11.8 Zebra Technologies Historical Sales: Revenue ($m), 2010-2014
Figure 12.1 EU Supply Chain Authentication Strategy, 2016
Figure 12.2 US Supply Chain Authentication Strategy, 2016
Figure 13.1 Leading Submarkets for the Pharmaceutical Anti-Counterfeiting Technologies Market: Revenue ($m) from 2015-2026
Figure 13.2 Leading National Markets for the Pharmaceutical Anti-Counterfeiting Technologies Market: Revenue ($m) from 2015-2026

★調査レポート[医薬品偽造防止技術の世界市場予測2016-2026] ( Pharmaceutical Anti-Counterfeiting Technologies Market Forecast 2016-2026 / VGAIN60629) 販売に関する免責事項
[医薬品偽造防止技術の世界市場予測2016-2026] ( Pharmaceutical Anti-Counterfeiting Technologies Market Forecast 2016-2026 / VGAIN60629) についてEメールでお問い合わせ
◆関連調査資料◆
  • 偽造防止包装技術の世界市場2016-2026
    VGAIN6012609 / visiongain / 2016年1月 / 当調査レポートでは、偽造防止包装技術の世界市場について調査・分析し、以下の構成でお届けいたします。 ・レポートの概要 ・イントロダクション ・偽造防止包装技術の役割 ・偽造防止包装技術の世界市場 　（市場規模予測、市場動向、市場の成長要因・阻害要因など） ・偽造防止包装技術の世界市場：セグメント別市場分析 ・偽造防止包装技術の世界市場：地域別市場分析、市場規模予測 ・市場環境分析 ・専門家の見解...The latest report from business intelligence provider visiongain offers comprehensive analysis of the global anti-counterfeit packaging technologies market. Visiongain assesses that this market will generate revenues of $18.14 bn in 2016. The trade of counterfeit goods is a trillion dollar industry and one of the fastest growing economic crimes worldwide. According to the World Customs Organisation, 7% of the total world trade is counterfeit. Today, counterfeit goods not only include luxury and high-priced items such as designer handbags, watches and perfumes, but also an array of illicit products such as medications, cigarettes, baby formula, toothpaste, electronic equipment & parts, airplane...
  • 医療産業向け包装パッケージの世界市場2016-2026
    VGAIN6012610 / visiongain / 2016年1月 / 当調査レポートでは、医療産業向け包装パッケージの世界市場について調査・分析し、以下の構成でお届けいたします。 ・レポートの概要 ・イントロダクション ・医療産業向け包装パッケージの世界市場 　（市場規模予測、市場動向、市場の成長要因・阻害要因など） ・医療産業向け包装パッケージの世界市場：需要先別市場分析 ・医療産業向け包装パッケージの世界市場：包装材料別市場分析 ・医療産業向け包装パッケージの世界市場：パッケージ種類別市場分析 ・医療産業向け包装パッケージの世界市場：地域別市場分析、市場規模予測 ・市場環境分析...The global healthcare packaging market is expected to experience a steady increase driven by several government reforms to healthcare systems across the world. Visiongain has published this unique report, which is crucial to your companies improved success. Your profitability and business opportunities could be enhanced by reading this report. Visiongain’s report keeps you informed and ahead of your competitors. Gain that competitive advantage. • This report answers questions such as: - How is the healthcare packaging market evolving? - What is driving and restraining the healthcare packaging market dynamics? - What are the markets shares of the end-use / materials...
  • 医薬品パッケージングの世界市場2016-2026
    VGAIN81915 / visiongain / 2016年7月 / 当調査レポートでは、医薬品パッケージングの世界市場について調査・分析し、医薬品パッケージングの世界市場規模、市場動向、市場予測、市場環境分析、専門家の見解、関連企業情報などを含め、以下の構成でお届けいたします。 1. レポート概要 2. 医薬品パッケージング市場の概要 3. 医薬品パッケージングの世界市場 4. 世界の医薬品パッケージング材2次市場予測 5....The global pharmaceutical packaging market is expected to expand, driven primarily by the Chinese, US, Japanese and European markets. These markets are highly competitive where local and international regulations play a relevant role. The pharmaceutical packaging market will also be driven by new pharmaceutical products, increasing demand for blister packaging, the growth in anti-counterfeiting and other sophisticated packaging, online printing technology, and investment in R&D across different therapeutic areas. Visiongain’s report keeps you informed and ahead of your competitors. Gain that competitive advantage. If you wish to maximise the opportunities within the $82.6bn pharmaceutical packaging market, then you need this...
  • 空カプセルの世界市場・産業予測2016-2026
    VGAIN61126 / visiongain / 2016年10月 / 当調査レポートでは、空カプセルの世界市場について調査・分析し、空カプセルの世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。 1. レポート概要 2. 空カプセル市場の概要 3. 空カプセルの世界市場2016-2026 4. 原料種類別の空カプセル世界市場予測2016-2026 5....The latest report from business intelligence provider visiongain offers comprehensive analysis of the global empty capsule market. The global empty capsules market was valued at $1,360m in 2015. Visiongain forecasts this market to increase to $1,944m in 2020. The market will then continue to increase to $3,074m in 2026, growing at a CAGR 6.8% between 2020 and 2026. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new report you find 298-page report you will receive 129 in-depth tables and 71 figures – all...
  • 医薬品卸売・物流の世界市場予測2016-2026
    VGAIN61117 / visiongain / 2016年9月 / 当調査レポートでは、医薬品卸売・物流の世界市場について調査・分析し、医薬品卸売・物流の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。 1. レポート概要 2. 医薬品卸売・物流の概要 3. 医薬品卸売・物流の世界市場：2015-2026 4. 医薬品卸売・物流産業：主要国市場2015-2026 5....Pharma Wholesaling and Distribution – Analysis of Companies, Trends and Future Revenues to Benefit Your Influence What does the future hold for drug wholesale and distribution (W&D) services? Discover revenue predictions there to 2026. And explore trends in those services and technologies, assessing prospects and finding opportunities to benefit your work and authority. In visiongain’s new report you gain revenue forecasts at overall world market, submarket, company and national level. There you assess potentials for expanding revenues. See where that industry’s best prospects lie. Please read on to explore activities of distributors and wholesalers of pharmaceuticals, discovering what that business’s...
  • スマートパッケージングの世界市場2016-2026
    VGAIN61116 / visiongain / 2016年10月 / 当調査レポートでは、スマートパッケージングの世界市場について調査・分析し、スマートパッケージングの世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。 1. レポート概要 2. スマートパッケージング市場の概要 3. スマートパッケージングの世界市場2016-2026 4. スマートパッケージングの需要先別2次市場2016-2026 5....Visiongain’s comprehensive new 214 page report reveals that the smart packaging market will achieve revenues of $31.1bn in 2016. Are you a packaging company involved in the smart packaging market or aim to enter this market space? If so, then you must read this report It’s vital that you keep your knowledge up to date. You need this report. Market scope: Smart packaging is the element of packaging that in addition to the traditional three functions of packaging products (protection, containment and communication), offers a number of extra functionalities. Here in this report, visiongain defines smart packaging as an umbrella...
  • 医薬品リーダーシリーズ：医薬品製造受託機関（CMO）上位30社2016-2026
    VGAIN61121 / visiongain / 2016年9月 / 当調査レポートでは、医薬品製造受託機関（CMO）上位30社について調査・分析し、以下の構成でお届けいたします。 1. レポート概要 2. 医薬品受託製造の概要2016 3. 北米の主要CMO（製造受託機関） 4. 欧州の主要製造受託機関 5....In its updated report, visiongain provides revenues to 2026 for the world pharmaceutical contract manufacturing organisations (CMO) market. This report also analyses leading companies in pharmaceutical contract manufacturing. The demand for outsourced drug production has grown rapidly in the past 10 years. The world market for pharma contract manufacturing was worth $61.6bn in 2015, having grown by more than 6% from 2014. The new study predicts strong growth in that industry’s revenue, reaching $84.0bn worldwide in 2020, with further expansion expected. Our 317-page report provides 185 tables, 110 figures and analysis of 30 leading companies. The content of each profile...
  • 医療機器委託製造の世界市場予測2016-2026
    VGAIN60622 / visiongain / 2016年5月 / 当調査レポートでは、医療機器委託製造の世界市場について調査・分析し、以下の構成でお届けいたします。 1. レポート概要 2. 医療機器委託製造: 概要 3. 医療機器委託製造市場 2016-2026 4....What can be expected from the Medical Device Contract Manufacturing Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects. Our 234-page report provides 152 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across all the major regional and national medical device contract manufacturing market. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market. Forecasts from 2016-2026...
  • OTC医薬品（市販薬）の世界市場予測2016-2026
    VGAIN6041529 / visiongain / 2016年3月 / ...What can be expected from the Over-the-Counter Pharmaceuticals Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects. Our 247-page report provides 148 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across the all the major categories of over-the-counter medicines market. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market. Forecasts from 2016-2026 and other analyses show...
  • 喘息＆COPDの世界市場2016-2026
    VGAIN61125 / visiongain / 2016年10月 / 当調査レポートでは、喘息＆COPDの世界市場について調査・分析し、喘息＆COPDの世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。 1. レポート概要 2. 喘息＆COPD治療の概要 3. 喘息＆COPD治療：世界市場2016-2026 4. 気管支拡張薬単剤治療市場2016-2026 5....Visiongain’s comprehensive new 313 page report reveals that the global asthma & COPD market will achieve revenues of $33.2bn in 2016. Are you involved in the asthma & COPD market or intend to be? If so, then you must read this report. It’s vital that you keep your knowledge up to date. You need this report. Market scope: Asthma & COPD are among the most common and debilitating respiratory conditions. Drugs for the treatment of these conditions fall into 3 main categories: Bronchodilator monotherapy, anti-inflammatory drugs and combination drugs. Visiongain assesses how these three submarkets and the 12 largest national...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆